Kung

Puzzles and Survival's All New Kung Fu Update Makes Its Offical Debut Today! Featuring a New Hero, the Warrior Monk Wuxin!

Retrieved on: 
Friday, September 1, 2023

WASHINGTON, Sept. 1, 2023 /PRNewswire/ -- Puzzles & Survival, the popular zombie-themed match-3 mobile strategy game published by 37 Games, is announcing the official release of a brand-new update, Puzzles & Survival x Kung Fu.

Key Points: 
  • WASHINGTON, Sept. 1, 2023 /PRNewswire/ -- Puzzles & Survival, the popular zombie-themed match-3 mobile strategy game published by 37 Games, is announcing the official release of a brand-new update, Puzzles & Survival x Kung Fu.
  • There are numerous Kung Fu-themed events designed specifically for this update, including the ability to meet and recruit a new hero, the warrior monk Wuxin!
  • Kung Fu, is not only about passing down physical skills but also about mastering the philosophy of Kung Fu.
  • And thanks to 37 Games, players can follow in the footsteps of the warrior monk Wuxin as they master the art of Kung Fu in Puzzles and Survival!

AMD expected to occupy over 20% of server CPU market and Arm 8% in 2023, according to DIGITIMES Research

Retrieved on: 
Thursday, February 23, 2023

TAIPEI, Feb. 22, 2023 /PRNewswire/ -- AMD and Arm have been gaining up on Intel in the server CPU market in the past few years, and the margins of the share that AMD had won over were especially large in 2022 as datacenter operators and server brands began finding that solutions from the number-2 maker growing superior to those of the long-time leader, according to Frank Kung, DIGITIMES Research analyst focusing primarily on the server industry, who anticipates that AMD's share will well stand above 20% in 2023, while Arm will get 8%.

Key Points: 
  • Prices are one of the three major drivers that resulted in datacenter operators and server brands switching to AMD.
  • Since Intel's and AMD's processors are both based on the x86 architecture, compatibility is not an issue that server companies need to worry about, Kung noted.
  • However, datacenter operators and server brands are still aggressive about Arm processors' development in the server market.
  • Chart 1: Server shipment share by CPU, 2020-2023
    Table 1: Server CPU roadmaps by supplier, 2021-2024

DynamX Bioadaptor Restores Rotational Motion and Vessel Stress Reduction in New Study

Retrieved on: 
Wednesday, June 1, 2022

The DynamX Bioadaptor is the first drug-eluting coronary artery implant that adapts to vessel physiology by incorporating flexible uncaging elements into its design.

Key Points: 
  • The DynamX Bioadaptor is the first drug-eluting coronary artery implant that adapts to vessel physiology by incorporating flexible uncaging elements into its design.
  • Computational modeling also indicated that peak rotational stress for the bioadaptor decreased by 70 percent with uncaging of the bioadaptor.
  • The DynamX Mechanistic Clinical Study previously showed that the bioadaptor enabled positive adaptive remodeling, preserving the vessel lumen to accommodate disease progression, as well as a return towards baseline vessel angulation and a strong safety profile.
  • This recent analysis now demonstrates the ability of the device to twist along with the vessels natural motion, and in doing so, subsequently reduce vessel stress.

Elixir Medical Completes Enrollment in BIOADAPTOR Randomized Controlled Trial of DynamX Coronary Bioadaptor System

Retrieved on: 
Tuesday, February 15, 2022

Elixir Medical , a developer of innovative, drug-eluting cardiovascular devices, today announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT).

Key Points: 
  • Elixir Medical , a developer of innovative, drug-eluting cardiovascular devices, today announced completion of enrollment in the BIOADAPTOR randomized controlled trial (RCT).
  • The BIOADAPTOR RCT is evaluating the DynamX Coronary Bioadaptor System , the first drug-eluting coronary artery implant that adapts to vessel physiology, allowing for the restoration of normal vessel functions essential to cardiovascular performance.
  • The DynamX Bioadaptor supports the coronary artery with radial strength and acute performance similar to DES during healing.
  • Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice.

utobo Announces Launch of the Elite206 Program

Retrieved on: 
Tuesday, December 21, 2021

PALO ALTO, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- utobo , the simplest platform to create, conduct, and sell online courses, has officially announced the launch of the Elite206 program.

Key Points: 
  • PALO ALTO, Calif., Dec. 21, 2021 (GLOBE NEWSWIRE) -- utobo , the simplest platform to create, conduct, and sell online courses, has officially announced the launch of the Elite206 program.
  • To bring this concept into reality, the team has developed Elite206 to help creators in their respective journeys to building successful online coaching brands.
  • Raj Sahu, the founder of utobo, has brought utobo to Silicon Valley - a goal he has had for the past decade.
  • Hundreds of creators from 20-plus countries are launching their courses using utobo without any technical knowledge.